User access denied after restriction

Biosimilars reduce drug costs by up to 70%, but patient access depends on insurance coverage and policy decisions.

Discover how obesity medications like semaglutide may help manage metabolic side effects from antipsychotics.

Learn why user access to Yesafili, a biosimilar for eye conditions like wAMD, may be restricted and how…

Zambia's delay in signing a health memorandum with the US stems from disagreements over data and specimen sharing,…

Lenacapavir for HIV PrEP accounted for only 1% of all PrEP in the first six months after FDA…

Learn why user access was denied after restriction policies changed, impacting employees like Ashley Holzworth-Nash at Express Scripts.

Users report website access blocks that are preventing login and restricting access to vital online services and digital…

Understanding primary and secondary FSGS disease classification helps with diagnosis and treatment of focal segmental glomerulosclerosis symptoms and…

Specialty drug costs rise 12.5% in 2025 driven by higher utilization and rebate adjustments, affecting specialty drug spending.

HIV prevention efforts in the U.S. have stalled due to unreliable PrEP surveillance data, leaving many without access…